MXPA04002560A - Combinacion de un nsaid y un inhibidor pde-4. - Google Patents

Combinacion de un nsaid y un inhibidor pde-4.

Info

Publication number
MXPA04002560A
MXPA04002560A MXPA04002560A MXPA04002560A MXPA04002560A MX PA04002560 A MXPA04002560 A MX PA04002560A MX PA04002560 A MXPA04002560 A MX PA04002560A MX PA04002560 A MXPA04002560 A MX PA04002560A MX PA04002560 A MXPA04002560 A MX PA04002560A
Authority
MX
Mexico
Prior art keywords
new combination
pde3
pde4
inhibitors
treatment
Prior art date
Application number
MXPA04002560A
Other languages
English (en)
Inventor
Beume Rolf
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of MXPA04002560A publication Critical patent/MXPA04002560A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se refiere a la administracion combinada de inhibidores de PDE4 o PDE3/4 y antagonistas receptores de leucotrieno para el tratamiento de desordenes del tracto respiratorio.
MXPA04002560A 2001-09-19 2002-09-17 Combinacion de un nsaid y un inhibidor pde-4. MXPA04002560A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01000474 2001-09-19
PCT/EP2002/010423 WO2003024488A2 (en) 2001-09-19 2002-09-17 Combination of a pde inhibitor and a leukotriene receptor antagonist

Publications (1)

Publication Number Publication Date
MXPA04002560A true MXPA04002560A (es) 2004-05-31

Family

ID=8176066

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002560A MXPA04002560A (es) 2001-09-19 2002-09-17 Combinacion de un nsaid y un inhibidor pde-4.

Country Status (26)

Country Link
US (1) US20050014762A1 (es)
EP (1) EP1429843B1 (es)
JP (1) JP2005505570A (es)
KR (1) KR20040044946A (es)
CN (1) CN100346831C (es)
AT (1) ATE349243T1 (es)
BR (1) BR0212582A (es)
CA (1) CA2460442A1 (es)
CO (1) CO5560584A2 (es)
CY (1) CY1106365T1 (es)
DE (1) DE60217139T2 (es)
DK (1) DK1429843T3 (es)
EA (1) EA007736B1 (es)
ES (1) ES2279004T3 (es)
HK (1) HK1066752A1 (es)
HU (1) HUP0500078A3 (es)
IL (2) IL160272A0 (es)
MA (1) MA27136A1 (es)
MX (1) MXPA04002560A (es)
NO (1) NO331885B1 (es)
NZ (1) NZ532279A (es)
PL (1) PL205927B1 (es)
PT (1) PT1429843E (es)
SI (1) SI1429843T1 (es)
WO (1) WO2003024488A2 (es)
ZA (1) ZA200402653B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719518D0 (en) * 2007-10-05 2007-11-14 Therapeutics Ltd E Therapy
WO2009052624A1 (en) * 2007-10-25 2009-04-30 Merck Frosst Canada Ltd. Combination therapy
WO2012168907A1 (en) 2011-06-10 2012-12-13 Glenmark Pharmaceuticals Sa Pharmaceutical composition comprising revamilast and montelukast or zafirlukast
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
PE20151332A1 (es) 2013-02-19 2015-09-20 Pfizer Compuestos de azabencimidazol
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof
US20160339010A1 (en) 2014-01-22 2016-11-24 Takeda Gmbh Treatment of Partly Controlled or Uncontrolled Severe Asthma
JP6713982B2 (ja) 2014-07-24 2020-06-24 ファイザー・インク ピラゾロピリミジン化合物
DK3177624T3 (da) 2014-08-06 2019-07-01 Pfizer Imidazopyridazinforbindelser

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028986A1 (es) * 1999-02-23 2003-06-04 Smithkline Beecham Corp USO DE UN INHIBIDOR DE PDE4 EN LA FABRICACIoN DE UNA PREPARACIoN DE LIBERACIoN CONTROLADA; FORMULACION DE LIBERACION CONTROLADA PARA EL TRATAMIENTO DE COPD, UN PROCEDIMIENTO PARA SU PREPARACIoN Y COMPOSICIoN FARMACÉUTICA
EA006685B1 (ru) * 1999-08-21 2006-02-24 Алтана Фарма Аг Синергетическая композиция
MY134008A (en) * 1999-12-22 2007-11-30 Merck Frosst Canada Inc Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors
MXPA02007419A (es) * 2000-01-31 2002-12-09 Pfizer Prod Inc Derivados de nicotinamida benzocondensada-heterociclilo utiles como inhibidores selectivos de las isozimas pde4.
MY123585A (en) * 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
AU6196201A (en) * 2000-05-25 2001-12-03 Merck Frosst Canada Inc Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor

Also Published As

Publication number Publication date
HK1066752A1 (en) 2005-04-01
WO2003024488A2 (en) 2003-03-27
US20050014762A1 (en) 2005-01-20
PL367414A1 (en) 2005-02-21
WO2003024488A3 (en) 2003-09-04
NO331885B1 (no) 2012-04-30
DE60217139T2 (de) 2007-10-04
EP1429843A2 (en) 2004-06-23
KR20040044946A (ko) 2004-05-31
CO5560584A2 (es) 2005-09-30
PT1429843E (pt) 2007-03-30
CA2460442A1 (en) 2003-03-27
BR0212582A (pt) 2004-10-13
SI1429843T1 (sl) 2007-06-30
CY1106365T1 (el) 2011-10-12
HUP0500078A2 (hu) 2005-04-28
EP1429843B1 (en) 2006-12-27
ES2279004T3 (es) 2007-08-16
EA007736B1 (ru) 2006-12-29
EA200400416A1 (ru) 2004-12-30
MA27136A1 (fr) 2005-01-03
NZ532279A (en) 2006-02-24
ZA200402653B (en) 2005-02-14
ATE349243T1 (de) 2007-01-15
DE60217139D1 (de) 2007-02-08
CN100346831C (zh) 2007-11-07
NO20041595L (no) 2004-06-16
HUP0500078A3 (en) 2010-07-28
JP2005505570A (ja) 2005-02-24
PL205927B1 (pl) 2010-06-30
IL160272A0 (en) 2004-07-25
IL160272A (en) 2008-03-20
CN1655846A (zh) 2005-08-17
DK1429843T3 (da) 2007-04-30

Similar Documents

Publication Publication Date Title
HUP0302476A3 (en) Use of acetylcholinesterase inhibitors and gabaainverse agonists for the treatment of cognitive disorders and for preparation of pharmaceutical compositins
HUP0302613A2 (hu) (+)-1-(3,4-Diklór-fenil)-3-azabiciklo[3.1.0]hexán, készítményei és felhasználásai
PL367142A1 (en) 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
NO20035025D0 (no) Anvendelse av osteopontin for behandling og/eller for å hindre nevrologiskesykdommer
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
MY124786A (en) Bis-arylsulfones
CY1106365T1 (el) Συνδυασμος ενος αναστολεα pde και ενος ανταγωνιστη υποδοχεων λευκοτριενιου
IL168308A (en) Compositions containing roflumilast and formoterol
IL158704A0 (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
IL198759A (en) Use of 3gal receptor antagonists to prepare medications to treat depression and / or anxiety
IL158703A0 (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
SG160197A1 (en) Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
IL158632A0 (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
IL158695A0 (en) 4-(phenyl-piperidin-4-yldine-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
AU2002339680A1 (en) Agonists and antagonists of bromix for the treatment of metabolic disorders
HUP0202416A3 (en) Novel pharmaceutical combination and it's use for the treatment of certain cardiovascular disorders
AU2002329001A1 (en) Agonists and antagonists of cylixin for the treatment of metabolic disorders
AU2002321766A1 (en) Agonists and antagonists of obesingen for the treatment of metabolic disorders
AU2002321761A1 (en) Agonists and antagonists of disomet for the treatment of metabolic disorders
AU2002339685A1 (en) Agonists and antagonists of oxifan for the treatment of metabolic disorders
ZA200309766B (en) Antihistamines for the treatment of nasal congestion and nasal obstruction.

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status
HC Change of company name or juridical status